MapLight Therapeutics, Inc.
MPLT
$30.67
$0.371.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Net Income | -274.71% | -54.71% | -62.21% | -17.98% | |
| Total Depreciation and Amortization | -27.84% | -27.27% | -21.39% | 12.93% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 48,901.43% | 67.88% | 92.87% | -82.23% | |
| Change in Net Operating Assets | -229.25% | -258.77% | -2,474.77% | -69.33% | |
| Cash from Operations | -117.93% | -60.12% | -93.74% | -28.13% | |
| Capital Expenditure | -254.72% | 91.71% | 77.08% | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -845.16% | -1,603.85% | 114.40% | -- | |
| Cash from Investing | -848.76% | -1,669.31% | 114.31% | 1,875,100.00% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 1,253,940.91% | 1,385.71% | -98.85% | 25.00% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -22,805.88% | -328.04% | 91.88% | -- | |
| Cash from Financing | 5,439,200.00% | 95,780.19% | 90.81% | -100.04% | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -259.63% | 368.62% | 88.17% | -88.10% | |